- Home
- UAL vs IQV Comparison
UAL vs IQV Comparison
Compare UAL & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAL | IQV |
|---|---|---|
| Founded | 1934 | 1982 |
| Country | United States | United States |
| Employees | 87000 | 93000 |
| Industry | Air Freight/Delivery Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9B | 27.9B |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | UAL | IQV |
|---|---|---|
| Price | $92.12 | $173.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 16 |
| Target Price | $130.59 | ★ $230.56 |
| AVG Volume (30 Days) | ★ 7.9M | 1.3M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.94 | 4.67 |
| EPS | ★ 10.20 | 7.84 |
| Revenue | ★ $37,736,000,000.00 | $9,739,000,000.00 |
| Revenue This Year | $9.97 | $6.77 |
| Revenue Next Year | $6.11 | $5.87 |
| P/E Ratio | ★ $9.32 | $22.00 |
| Revenue Growth | 3.23 | ★ 41.60 |
| 52 Week Low | $52.00 | $134.65 |
| 52 Week High | $119.21 | $247.05 |
Technical Indicators
Market Signals| Indicator | UAL | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 50.62 |
| Support Level | $86.92 | $157.59 |
| Resistance Level | $95.32 | $193.26 |
| Average True Range (ATR) | 4.40 | 5.86 |
| MACD | 0.77 | 1.87 |
| Stochastic Oscillator | 57.43 | 71.27 |
Price Performance
Historical ComparisonAbout UAL United Airlines Holdings Inc.
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.